- Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study
-
Ceresoli M, Verrengia , Montori G, Busci L, Coccolini , Ansaloni L, Frigerio L
- KMID: 2409946
- J Gynecol Oncol.
- 2018 May;29(3):e53.
- doi: 10.3802/jgo.2018.29.e53
OBJECTIVE: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been proposed as a treatment in ovarian cancer. A recently published RCT demonstrated that HIPEC prolongs disease-free survival (DFS) and overall survival (OS) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study
-
Coccolini , Campanati , Catena F, Ceni V, Ceresoli M, Jimenez Cruz J, Lotti M, Magnone S, Napoli J, Rossetti D, De Iaco P, Frigerio L, Pinna A, Runnebaum , Ansaloni L
- KMID: 2158803
- J Gynecol Oncol.
- 2015 Jan;26(1):54-61.
- doi: 10.3802/jgo.2015.26.1.54
OBJECTIVE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been recently reported with favorable oncological outcomes as treatment of advanced epithelial ovarian cancer (EOC). The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
